Hepatitis B Vaccine (Recombinant) Completed Phase 3 Trials for Meningococcal Serogroup C Diseases / Haemophilus Influenzae Type b Diseases / Neisseria Meningitidis / Haemophilus Influenzae Type B Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00322335Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
NCT01000974Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants